Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target (Q37596851)
scientific article published on 03 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target |
scientific article published on 03 October 2013 |
Statements
1 reference
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target (English)
1 reference
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target (English)
1 reference
gene expression regulation, neoplastic
Anneleen Daemen
1 reference
Kornelia Polyak
1 reference
Joe W Gray
1 reference
Laura J van 't Veer
1 reference
Thomas Holton
1 reference
Mariia Yuneva
1 reference
Mercè Padró
1 reference
Min Hu
1 reference
Frank McCormick
1 reference
Luika A. Timmerman
Raymond J. Louie
Denise A. Chan
Stephen P. Ethier
Laura J. van 't Veer
3 October 2013
1 reference
1 reference
1 reference
450-465
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference